Microvesicles derived from human Wharton's jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Du, Tao ^b   Ju, Guanqun ^a   Wu, Shuai ^a,c   Cheng, Zhongliang ^a   Cheng, Jun ^d   Zou, Xiangyu ^a   Zhang, Guangyuan ^a   Miao, Shuai ^a   Liu, Guohua ^a   Zhu, Yingjian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c QINGDAO MUNICIPAL HOSPITAL   (China)

^d Nantong Tongzhou People's Hospital   (China)

Author keywords

2014 du et al.

Indexed keywords

CYCLIN D1; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RIBONUCLEASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; CULTURE MEDIUM; HGF PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL VACUOLE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KIDNEY CANCER; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MICROVESICLE; MOUSE; NICK END LABELING; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; KIDNEY; KIDNEY TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WHARTON JELLY; WOUND HEALING;

ANIMALS; CELL COMMUNICATION; CELL CYCLE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; CYCLIN D1; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEASES; SIGNAL TRANSDUCTION; WHARTON JELLY; WOUND HEALING;

EID: 84900384847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096836     Document Type: Article

References (49)

1. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, et al. (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608. (Pubitemid 34728832)
2. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, et al. (2004) Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents. JNCI Journal of the National Cancer Institute 96: 1593-1603. (Pubitemid 39534883)
3. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563. (Pubitemid 47525152)
4. Roorda BD, ter Elst A, Kamps WA, de Bont ESJM (2009) Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Critical Reviews in Oncology/Hematology 69: 187-198.
5. Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, et al. (2010) Mesenchymal stem cells enhance growth and metastasis of colon cancer. International Journal of Cancer 127: 2323-2333.
6. Han Z, Tian Z, Lv G, Zhang L, Jiang G, et al. (2011) Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. Journal of Cellular and Molecular Medicine 15: 2343-2352.
7. Djouad F (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844.
8. Rubio D, Garcia S, De la Cueva T, Paz MF, Lloyd AC, et al. (2008) Human mesenchymal stem cell transformation is associated with a mesenchymal- epithelial transition. Experimental Cell Research 314: 691-698.
9. Blagosklonny MV, Spaeth EL, Dembinski JL, Sasser AK, Watson K, et al. (2009) Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression. PLoS ONE 4: e4992.
10. Bouffi C, Djouad F, Mathieu M, Noel D, Jorgensen C (2009) Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology 48: 1185-1189.
11. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney International 78: 838-848.
12. Simons M, Raposo G (2009) Exosomes - vesicular carriers for intercellular communication. Curr Opin Cell Biol 21: 575-581.
13. Aliotta JM, Lee D, Puente N, Faradyan S, Sears EH, et al. (2012) Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells Dev 21: 1627-1638.
14. Wu S, Ju GQ, Du T, Zhu YJ, Liu GH (2013) Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS One 8: e61366.
15. Ma PC, Tretiakova MS, MacKinnon AC, Ramnath N, Johnson C, et al. (2008) Expression and mutational analysis ofMETin human solid cancers. Genes, Chromosomes and Cancer 47: 1025-1037.
16. Du T, Zou X, Cheng J, Wu S, Zhong L, et al. (2013) Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Stem Cell Res Ther 4: 59.
17. Du T, Cheng J, Zhong L, Zhao XF, Zhu J, et al. (2012) The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy 14: 1215-1227.
18. Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148-154. (Pubitemid 19163397)
19. Banumathy G, Cairns P (2010) Signaling pathways in renal cell carcinoma. Cancer Biol Ther 10: 658-664.
20. Huang D, Ding Y, Luo WM, Bender S, Qian CN, et al. (2008) Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res 68: 81-88. (Pubitemid 351380108)
21. Sierra JR, Tsao M-S (2011) c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 3: S21-S35.
22. Navab R, Liu J, Seiden-Long I, Shih W, MingLi, et al. (2009) Co-overexpression of Met and Hepatocyte Growth Factor Promotes Systemic Metastasis in NCIH460 Non - Small Cell Lung Carcinoma Cells. Neoplasia 11: 1292-1300.
23. Miyata Y (2006) Presence of Phosphorylated Hepatocyte Growth Factor Receptor/c-Met Is Associated with Tumor Progression and Survival in Patients with Conventional Renal Cell Carcinoma. Clinical Cancer Research 12: 4876-4881.
24. Aune G, Lian A-M, Tingulstad S, Torp SH, Forsmo S, et al. (2011) Increased circulating hepatocyte growth factor (HGF): A marker of epithelial ovarian cancer and an indicator of poor prognosis. Gynecologic Oncology 121: 402-406.
25. Kammula US, Kuntz EJ, Francone TD, Zeng Z, Shia J, et al. (2007) Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Letters 248: 219-228. (Pubitemid 46330555)
26. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925. (Pubitemid 37493640)
27. Quesenberry PJ, Dooner MS, Aliotta JM (2010) Stem cell plasticity revisited: The continuum marrow model and phenotypic changes mediated by microvesicles. Experimental Hematology 38: 581-592.
28. Janowska-Wieczorek A (2001) Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98: 3143- 3149.
29. Lösche W, Scholz T, Temmler U, Oberle V, Claus RA (2004) Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 15: 109-115. (Pubitemid 38316710)
30. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 9: 654-659. (Pubitemid 47214727)
31. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, et al. (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110: 2440-2448. (Pubitemid 47523165)
32. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, et al. (2009) Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles. PLoS One 4: e4722.
33. Katakowski M, Buller B, Wang X, Rogers T, Chopp M (2010) Functional MicroRNA Is Transferred between Glioma Cells. Cancer Res 70: 8259-8263.
34. Bruno S, Collino F, Deregibus MC, Grange C, Tetta C, et al. (2013) Microvesicles Derived from Human Bone Marrow Mesenchymal Stem Cells Inhibit Tumor Growth. Stem Cells and Development 22: 758-771.
35. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, et al. (2012) Human Liver Stem Cell-Derived Microvesicles Inhibit Hepatoma Growth in SCID Mice by Delivering Antitumor MicroRNAs. Stem Cells 30: 1985-1998.
36. Walker JL, Assoian RK (2005) Integrin-dependent signal transduction regulating cyclin D1 expression and G1 phase cell cycle progression. Cancer Metastasis Rev 24: 383-393. (Pubitemid 41569978)
37. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, et al. (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20: 1053-1067.
38. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, et al. (2011) Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26: 1474-1483.
39. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, et al. (2010) Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14: 1605-1618.
40. Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G (2012) Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27: 3037-3042.
41. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2: 161-174. (Pubitemid 37328786)
42. Nakamura T, Sakai K, Nakamura T, Matsumoto K (2011) Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 26 Suppl 1: 188-202.
43. Shon S-K, Kim A, Kim JY, Kim KI, Yang Y, et al. (2009) Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun 385: 198-203.
44. Hong JS, Greenlee KJ, Pitchumani R, Lee SH, Song Lz, et al. (2011) Dual Protective Mechanisms of Matrix Metalloproteinases 2 and 9 in Immune Defense against Streptococcus pneumoniae. The Journal of Immunology 186: 6427-6436.
45. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, et al. (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20: 847-856.
46. Nabeshima K, Inoue T, Shimao Y, Okada Y, Itoh Y, et al. (2000) Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Res 60: 3364-3369. (Pubitemid 30482147)
47. Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, et al. (1998) Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res 58: 5221-5230. (Pubitemid 28521186)
48. Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, et al. (2012) Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26: 1166-1173.
49. Zhu W, Huang L, Li Y, Zhang X, Gu J, et al. (2012) Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 315: 28-37.